Activity of PD-1 Inhibitor Combined With Anti-Angiogenic Therapy in Advanced Sarcoma: A Single-Center Retrospective AnalysisYang You, Yuhong Zhou, Xi Guo et al.|Frontiers in Molecular Biosciences|2021Cited by 35
Toripalimab in advanced biliary tract cancerWei Li, Tianshu Liu, Yueqi Wang et al.|The Innovation|2022Cited by 21
Integrated genomic and transcriptomic analysis revealed mutation patterns of de-differentiated liposarcoma and leiomyosarcomaWenshuai Liu, Yuhong Zhou, Feng Shen et al.|BMC Cancer|2020Cited by 17
<p>Efficacy and Resistance of ALK Inhibitors in Two Inflammatory Myofibroblastic Tumor Patients with ALK Fusions Assessed by Whole Exome and RNA Sequencing</p>Chenlu Zhang, Yuhong Zhou, Zhiming Wang et al.|OncoTargets and Therapy|2020Cited by 15
Lipidomics and Transcriptomics Differ Liposarcoma Differentiation Characteristics That Can Be Altered by Pentose Phosphate Pathway InterventionZhengqing Song, Yuhong Zhou, Shuai-Kang Wang et al.|Metabolites|2022Cited by 10